Medtronic – Management commits to faster organic sales growth, will they deliver?
With Medtronic’s fiscal Q1 quarterly results came the news that two new independent directors had been added to the Board and after Elliott Investment Management became one of its largest shareholders. The WSJ reported , “The activist investor and the medical-device maker have been holding friendly talks around how to boost the company’s valuation and build on ongoing plans to focus on core assets.” Notable from the earnings call, was management’s aim to accelerate top-line growth for the remainder of the fiscal year and beyond, which was one of the “asks” by Elliot per CNBC.
2 minutes

LOGIN









